Loading…

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

Colorectal cancer is the second leading cause of death from cancer in the United States. Metastases in the liver, the most common metastatic site for colorectal cancer, are found in one-third of the patients who die of colorectal cancer. Currently, the genes and molecular mechanisms that are functio...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2011-11, Vol.121 (11), p.4526-4536
Main Authors: Ding, Qingqing, Chang, Chun-Ju, Xie, Xiaoming, Xia, Weiya, Yang, Jer-Yen, Wang, Shao-Chun, Wang, Yan, Xia, Jiahong, Chen, Libo, Cai, Changchun, Li, Huabin, Yen, Chia-Jui, Kuo, Hsu-Ping, Lee, Dung-Fang, Lang, Jingyu, Huo, Longfei, Cheng, Xiaoyun, Chen, Yun-Ju, Li, Chia-Wei, Jeng, Long-Bin, Hsu, Jennifer L, Li, Long-Yuan, Tan, Alai, Curley, Steven A, Ellis, Lee M, Dubois, Raymond N, Hung, Mien-Chie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer is the second leading cause of death from cancer in the United States. Metastases in the liver, the most common metastatic site for colorectal cancer, are found in one-third of the patients who die of colorectal cancer. Currently, the genes and molecular mechanisms that are functionally critical in modulating colorectal cancer hepatic metastasis remain unclear. Here, we report our studies using functional selection in an orthotopic mouse model of colorectal cancer to identify a set of genes that play an important role in mediating colorectal cancer liver metastasis. These genes included APOBEC3G, CD133, LIPC, and S100P. Clinically, we found these genes to be highly expressed in a cohort of human hepatic metastasis and their primary colorectal tumors, suggesting that it might be possible to use these genes to predict the likelihood of hepatic metastasis. We have further revealed what we believe to be a novel mechanism in which APOBEC3G promotes colorectal cancer hepatic metastasis through inhibition of miR-29-mediated suppression of MMP2. Together, our data elucidate key factors and mechanisms involved in colorectal cancer liver metastasis, which could be potential targets for diagnosis and treatment.
ISSN:0021-9738
1558-8238
DOI:10.1172/jci45008